Bio-Path Holdings, Inc.
BPTH
$0.10
-$0.02-16.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 514.00K | 1.26M | 808.00K | 1.32M | 1.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.56M | 3.24M | 2.63M | 2.63M | 3.04M |
| Operating Income | -4.56M | -3.24M | -2.63M | -2.63M | -3.04M |
| Income Before Tax | -4.60M | -2.85M | -2.75M | -2.12M | -1.87M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.60M | -2.85M | -2.75M | -2.12M | -1.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.60M | -2.85M | -2.75M | -2.12M | -1.87M |
| EBIT | -4.56M | -3.24M | -2.63M | -2.63M | -3.04M |
| EBITDA | -4.55M | -3.24M | -2.61M | -2.63M | -3.03M |
| EPS Basic | -0.55 | -0.40 | -0.64 | -0.70 | -1.16 |
| Normalized Basic EPS | -0.35 | -0.25 | -0.40 | -0.44 | -0.72 |
| EPS Diluted | -0.55 | -0.40 | -0.64 | -0.70 | -1.16 |
| Normalized Diluted EPS | -0.35 | -0.25 | -0.40 | -0.44 | -0.72 |
| Average Basic Shares Outstanding | 8.31M | 7.06M | 4.32M | 3.02M | 1.61M |
| Average Diluted Shares Outstanding | 8.31M | 7.06M | 4.32M | 3.02M | 1.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |